Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation.
Maravelia P, Yao H, Cai C, Nascimento Silva D, Fransson J, Nilsson OB, Lu YW, Micke P, Botling J, Gatto F, Rovesti G, Carlsten M, Sallberg M, Stål P, Jorns C, Buggert M, Pasetto A.
Maravelia P, et al.
Gut. 2025 Jan 19:gutjnl-2024-334148. doi: 10.1136/gutjnl-2024-334148. Online ahead of print.
Gut. 2025.
PMID: 39832892
Free article.